An emphasis on the interaction of signaling pathways highlights the role of miRNAs in the etiology and treatment resistance of gastric cancer

D Fathi, MS Elballal, AE Elesawy, AI Abulsoud… - Life Sciences, 2023 - Elsevier
Gastric cancer (GC) is 4th in incidence and mortality rates globally. Several genetic and
epigenetic factors, including microRNAs (miRNAs), affect its initiation and progression …

[HTML][HTML] The role of Insulin-like growth factor 2 mRNA-binding proteins (IGF2BPs) as m6A readers in cancer

CY Sun, D Cao, BB Du, CW Chen… - International Journal of …, 2022 - ncbi.nlm.nih.gov
RNA can be modified by over 170 types of distinct chemical modifications, and the most
abundant internal modification of mRNA in eukaryotes is N6-methyladenosine (m 6 A). The …

METTL3/IGF2BP3 axis inhibits tumor immune surveillance by upregulating N6-methyladenosine modification of PD-L1 mRNA in breast cancer

W Wan, X Ao, Q Chen, Y Yu, L Ao, W Xing, W Guo… - Molecular cancer, 2022 - Springer
Background Continual expression of PD-L1 in tumor cells is critical for tumor immune
escape and host T cell exhaustion, however, knowledge on its clinical benefits through …

m6A RNA methylation-mediated NDUFA4 promotes cell proliferation and metabolism in gastric cancer

W Xu, Y Lai, Y Pan, M Tan, Y Ma, H Sheng… - Cell death & …, 2022 - nature.com
Gastric cancer (GC) is a malignancy with poor prognosis. NDUFA4 is reported to correlate
with the progression of GC. However, its underlying mechanism in GC is unknown. Our …

IGF2BP3 from physiology to cancer: novel discoveries, unsolved issues, and future perspectives

C Mancarella, K Scotlandi - Frontiers in cell and developmental …, 2020 - frontiersin.org
RNA network control is a key aspect of proper cellular homeostasis. In this context, RNA-
binding proteins (RBPs) play a major role as regulators of the RNA life cycle due to their …

CircRNA circHIPK3 serves as a prognostic marker to promote glioma progression by regulating miR-654/IGF2BP3 signaling

P Jin, Y Huang, P Zhu, Y Zou, T Shao… - … and biophysical research …, 2018 - Elsevier
Emerging evidences show RNA back-splicing produces a new type of noncoding RNA,
namely circular RNA (circRNA). Many reports demonstrate that circRNA circHIPK3 exerts …

IGF2BP3 promotes the progression of colorectal cancer and mediates cetuximab resistance by stabilizing EGFR mRNA in an m6A-dependent manner

LJ Chen, HY Liu, ZY Xiao, T Qiu, D Zhang… - Cell Death & …, 2023 - nature.com
Insulin-like growth factor 2 mRNA-binding protein 3 (IGF2BP3), an RNA-binding protein, is
associated with tumorigenesis and progression. However, the exact molecular mechanisms …

Comprehensive analysis of PD-L1 expression, immune infiltrates, and m6A RNA methylation regulators in esophageal squamous cell carcinoma

W Guo, F Tan, Q Huai, Z Wang, F Shao… - Frontiers in …, 2021 - frontiersin.org
Background Esophageal squamous cell carcinoma (ESCC) is one of the most common
cancer types and represents a threat to global public health. N6-Methyladenosine (m6A) …

The comprehensive landscape of miR-34a in cancer research

S Li, X Wei, J He, Q Cao, D Du, X Zhan, Y Zeng… - Cancer and Metastasis …, 2021 - Springer
Abstract MicroRNA-34 (miR-34) plays central roles in human diseases, especially cancers.
Inactivation of miR-34 is detected in cancer cell lines and tumor tissues versus normal …

Expression of m6A regulators correlated with immune microenvironment predicts therapeutic efficacy and prognosis in gliomas

S Xu, L Tang, G Dai, C Luo, Z Liu - Frontiers in cell and …, 2020 - frontiersin.org
Background N6-methyladenosine (m6A) RNA methylation and tumor immune
microenvironment played crucial roles in cancer development. However, their association in …